WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong · Delayed Price · Currency is HKD 40.00
-1.34 (-3.24%)
Feb 13, 2026, 4:08 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 165.5 billion as of February 12, 2026. Its market cap has increased by 129.02% in one year.
Market Cap
165.50B
Enterprise Value
161.86B
Revenue
21.98B
Ranking
n/a
PE Ratio
36.93
Stock Price
40.00
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 165.50B, an increase of 416.57%. That is a compound annual growth rate of 20.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 171.05B | 31.61% |
| Dec 31, 2025 | 129.96B | 80.25% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 301.65B |
| Innovent Biologics | 155.56B |
| Sino Biopharmaceutical | 121.38B |
| Sichuan Kelun-Biotech Biopharmaceutical | 101.95B |
| Akeso | 93.68B |
| 3SBio | 61.19B |
| RemeGen | 59.41B |
| Shanghai Henlius Biotech | 39.10B |